Group 1 - The core viewpoint of the article highlights the impressive debut of the domestic surgical robot leader, Precision Medical-B (2675.HK), which saw its stock price rise over 38% on its first trading day, reaching a market capitalization of HKD 23.2 billion [1] - The IPO price was set at HKD 43.24 per share, with the public offering receiving a subscription rate of 1,091.94 times and the international offering at 25.18 times, indicating strong investor interest [1] - Precision Medical focuses on the design, development, and manufacturing of surgical robots, with three products at different stages of research and development, including multi-port, single-port laparoscopic surgical robots, and natural orifice surgical robots [1] Group 2 - The company is the third surgical robot enterprise to be listed in China, and its fundraising attracted a prestigious lineup of cornerstone investors, including the Abu Dhabi Investment Authority, UBS Asset Management, and Obor Capital, collectively subscribing USD 75 million, reflecting confidence in its value prospects [1]
精锋医疗-B：首日上市涨超38%，募资获顶级机构认购